Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development

In BAAR, Switzerland, Evinova, a prominent company in AI-native clinical development technology, has revealed a fresh long-term strategic partnership with Merck KGaA, Darmstadt, Germany, a top science and technology organization. This collaboration aims to expedite global clinical development processes. Merck KGaA, Darmstadt, Germany will integrate the comprehensive features of the Evinova AI-Native platform into their operations, encompassing study design, document authoring, and downstream automation. This integration is projected to notably decrease the time involved in these processes.